TickerFacts.

Orthofix Medical Inc. (OFIX): Cost of Revenue

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2010-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$256.30M
Year ended 2025-12-31
$239.07M
Trailing 12 months to 2026-06-30
+27.5%
3-year compound annual growth
+20.3%
5-year compound annual growth
+11.5%
10-year compound annual growth
$260.37M2009-12-31: $138.45M2010-12-31: $97.09M2011-12-31: $96.42M2012-12-31: $100.73M2013-12-31: $106.91M2014-12-31: $98.91M2015-12-31: $86.53M2016-12-31: $87.85M2017-12-31: $93.04M2018-12-31: $96.63M2019-12-31: $100.61M2020-12-31: $101.89M2021-12-31: $114.91M2022-12-31: $123.54M2023-12-31: $260.37M2024-12-31: $253.61M2025-12-31: $256.30M$256.30M
2009-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$256.30M+1.1%2026-02-24, From 2025-01-01
2024-12-31$253.61M-2.6%2026-02-24, From 2024-01-01
2023-12-31$260.37M+110.7%2026-02-24, From 2023-01-01
2022-12-31$123.54M+7.5%2025-02-25, From 2022-01-01
2021-12-31$114.91M+12.8%2024-03-05, From 2021-01-01
2020-12-31$101.89M+1.3%2023-03-06, From 2020-01-01
2019-12-31$100.61M+4.1%2022-02-25, From 2019-01-01
2018-12-31$96.63M+3.9%2021-02-26, From 2018-01-01
2017-12-31$93.04M+5.9%2020-02-24, From 2017-01-01
2016-12-31$87.85M+1.5%2019-02-25, From 2016-01-01
2015-12-31$86.53M-12.5%2018-02-26, From 2015-01-01
2014-12-31$98.91M-7.5%2017-02-27, From 2014-01-01
2013-12-31$106.91M+6.1%2016-02-29, From 2013-01-01
2012-12-31$100.73M+4.5%2015-04-29, From 2012-01-01
2011-12-31$96.42M-0.7%2015-03-31, From 2011-01-01
2010-12-31$97.09Mn/c2014-03-24, From 2010-01-01
2009-12-31$138.45Mn/a2012-02-29, From 2009-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Orthofix Medical Inc. (OFIX)2025-12-31$256.30M+1.1%
Alphatec Holdings, Inc. (ATEC)2025-12-31$232.27M+24.0%
iRhythm Holdings, Inc. (IRTC)2025-12-31$219.89M+19.3%
Inspire Medical Systems, Inc. (INSP)2025-12-31$133.22M+8.3%
Tandem Diabetes Care Inc (TNDM)2025-12-31$468.72M+4.0%
NovoCure Ltd (NVCR)2025-12-31$166.88M+21.6%
Embecta Corp. (EMBC)2025-09-30$403.60M+4.0%
UFP Technologies Inc (UFPT)2025-12-31$432.39M+20.9%
Bioventus Inc. (BVS)2025-12-31$179.93M-2.8%

Compare OFIX, ATEC, IRTC, INSP side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗